What eHealth, Inc. told the SEC could break it.

Commission revenue is concentrated in a few insurance carriers: Humana was 35% and UnitedHealthcare 23% of total revenue in 2025 (~58% combined), so changes to a single carrier's commissions or relationship would materially affect results.

“Carriers representing 10% or more of our total revenue are summarized as follows. The majority of the revenue was from the Medicare segment. Year Ended December 31, 2025 2024 Humana 35 % 24 % UnitedHealthcare (1) 23 % 22 % Aetna (1) 5 % 18 %”

As a nationwide health insurance distributor, eHealth is heavily regulated by state and federal authorities, with Medicare Advantage marketing rules and annual CMS rate/STAR-rating methodology changes directly affecting carrier economics and its commissions.

“The health insurance industry is heavily regulated, and subject to extensive state and federal oversight.”

eHealth maintains operations in China that could need to be relocated or closed if U.S.-China relations deteriorate, disrupting its technology/operations support.

“Any material deterioration in U.S.-China relations could require us to relocate additional aspects of our operations in China or close our operations in China entirely, which could be time-consuming, expensive, disruptive and harmful to our business, operating results and financial condition.”

eHealth's revolving credit facility is secured by substantially all of its assets (default permits the lender to seize collateral), and it has $225M of H.I.G. Series A convertible preferred with negative operating covenants.

“It would also permit our lender to exercise rights and remedies with respect to all of the collateral that is securing the Revolving Credit Agreement, which includes substantially all of our assets.”